16-69749044-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_014062.3(NOB1):āc.600C>Gā(p.Asp200Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000108 in 1,614,120 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_014062.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NOB1 | NM_014062.3 | c.600C>G | p.Asp200Glu | missense_variant | 6/9 | ENST00000268802.10 | |
NOB1 | NR_074074.2 | n.485C>G | non_coding_transcript_exon_variant | 5/8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NOB1 | ENST00000268802.10 | c.600C>G | p.Asp200Glu | missense_variant | 6/9 | 1 | NM_014062.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000985 AC: 15AN: 152228Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000127 AC: 32AN: 251444Hom.: 0 AF XY: 0.000132 AC XY: 18AN XY: 135888
GnomAD4 exome AF: 0.000109 AC: 159AN: 1461892Hom.: 1 Cov.: 34 AF XY: 0.000117 AC XY: 85AN XY: 727248
GnomAD4 genome AF: 0.0000985 AC: 15AN: 152228Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74360
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 22, 2023 | The c.600C>G (p.D200E) alteration is located in exon 6 (coding exon 6) of the NOB1 gene. This alteration results from a C to G substitution at nucleotide position 600, causing the aspartic acid (D) at amino acid position 200 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at